BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28265706)

  • 1. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1911-1918. PubMed ID: 28265706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
    Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
    Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear Cell Renal Cell Carcinoma: Identifying the Loss of the Y Chromosome on Multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Aug; 209(2):333-338. PubMed ID: 28504543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell renal cell carcinoma: identifying PTEN expression on multiphasic MDCT.
    Young JR; Coy H; Kim HJ; Douek M; Sisk A; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2018 Dec; 43(12):3410-3417. PubMed ID: 29946925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell renal cell carcinoma: identifying the gain of chromosome 12 on multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2017 Jan; 42(1):236-241. PubMed ID: 27519835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT.
    Young JR; Young JA; Margolis DJ; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Abdom Radiol (NY); 2016 Nov; 41(11):2175-2181. PubMed ID: 27315079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Young JA; Hsu M; Raman SS
    Abdom Imaging; 2014 Jun; 39(3):543-9. PubMed ID: 24573763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
    Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
    AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma.
    Chaudhry HS; Davenport MS; Nieman CM; Ho LM; Neville AM
    AJR Am J Roentgenol; 2012 Feb; 198(2):377-83. PubMed ID: 22268181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
    Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
    Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression.
    Young JR; Coy H; Kim HJ; Douek M; Sisk A; Belldegrun A; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2018 Oct; 43(10):2734-2742. PubMed ID: 29520426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
    Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
    Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
    Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
    Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
    Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
    Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.